Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2020-04-10 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20200410 Verwerving en vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Verwerving en vervreemding van eigen aandelen" (Acquisition and disposal of own shares) and details transactions where UCB NV bought back its own shares (Aandelen Inkoopprogramma 2020) and disposed of shares related to employee incentive plans. This activity directly relates to the company's share capital management and transactions involving its own stock. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement ('gereglementeerde informatie') detailing specific transactions over a period (April 3 to April 9, 2020), not just an announcement that a report is forthcoming.
2020-04-10 Dutch
NBB_0019_31.12.2019_EN Final Signed.pdf
Audit Report / Information Classification · 1% confidence The document explicitly states it contains 'ANNUAL ACCOUNTS AND OTHER DOCUMENTS TO BE FILED UNDER BELGIAN COMPANY LAW'. It details the company identification, the financial year (ending 31/12/2019), the approval date (30/04/2020), and presents detailed financial statements like the 'BALANCE SHEET AFTER APPROPRIATION'. This structure and content are characteristic of a statutory annual financial report. Although the US equivalent is 10-K, the provided definitions map comprehensive yearly reports to '10-K'. Since this is a full annual report, '10-K' is the most appropriate classification among the choices, despite the Belgian jurisdiction, as it represents the annual filing of complete financial performance. FY 2019
2020-04-10 English
Procuration Assemblée Générale 30 avril 2020 (AR) final.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled "PROCURATION POUR L'ASSEMBLÉE GÉNÉRALE DES ACTIONNAIRES DU 30 AVRIL 2020" (Proxy for the General Shareholders' Meeting of April 30, 2020). It is a form for shareholders to grant proxy votes for an upcoming meeting, detailing the agenda items, which include the approval of annual accounts, remuneration reports, director re-elections, and amendments to statutes. This material is directly related to soliciting shareholder votes and providing necessary information for the General Meeting. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). Although it covers items typically found in an AGM or Annual Report context, the document itself is the proxy form used to facilitate voting at the AGM.
2020-04-10 French
NBB_0019_31.12.2019_NL Final signed.pdf
Annual Report Classification · 1% confidence The document is a formal 'Jaarrekening' (Annual Accounts) for UCB SA, a Belgian company. It contains detailed balance sheets, lists of directors, and financial data for the fiscal year 2018/2019. As it provides comprehensive financial statements and analysis for a specific period, it qualifies as an Annual Report (10-K equivalent in this context). FY 2018
2020-04-10 Dutch
Proxy General Meeting 30 April 2020 (Royal Decree) final.pdf
AGM Information Classification · 1% confidence The document is explicitly titled "PROXY FOR THE GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON 30 APRIL 2020". It contains voting instructions, resolutions for approval (e.g., annual accounts, remuneration report, director renewals), and details about attending or being represented at a General Meeting. This content perfectly matches the definition of materials related to a shareholder meeting, specifically a proxy form used to grant voting rights. The closest specific category is 'Proxy Solicitation & Information Statement' (PSI), as this document is the proxy form itself used to solicit votes for the AGM. While it covers AGM topics, the primary function and format are that of a proxy solicitation document.
2020-04-10 English
Procuration Assemblée Générale 30 avril 2020 (Finale).pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is explicitly titled "PROCURATION POUR L'ASSEMBLÉE GÉNÉRALE DES ACTIONNAIRES DU 30 AVRIL 2020" (Proxy for the Shareholders' General Meeting of April 30, 2020). It contains instructions for shareholders to appoint a proxy to vote on various resolutions, including the approval of annual accounts, remuneration reports, director re-elections, and capital plans. This material is used to solicit shareholder votes for a general meeting. The closest matching category is 'Proxy Solicitation & Information Statement' (PSI). While it relates to the AGM, the document itself is the proxy form/information sent to solicit votes, not the AGM presentation (AGM-R) or the final voting results (DVA).
2020-04-10 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.